(Q50910086)

English

Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses.

scientific article published on 13 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23764428%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23764428%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Dario Domenico Lofrumento

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23764428%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Giuseppe Nicolardi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23764428%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23764428%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

5

object named as

Velia La Pesa

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23764428%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Antonia Cianciulli

3

object named as

Antonia Cianciulli

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23764428%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Francesco De Nuccio

4

object named as

Francesco De Nuccio

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23764428%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Vito Carofiglio

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23764428%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Teresa Dragone

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23764428%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Maria A Panaro

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23764428%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

13 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23764428%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Innate Immunity

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23764428%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23764428%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23764428%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

249-260

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23764428%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Levodopa for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Parkinson's disease: mechanisms and models

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Microglia in health and disease

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2.

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Biological effects of resveratrol

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism.

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults.

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

MPTP-induced neuroinflammation increases the expression of pro-inflammatory cytokines and their receptors in mouse brain.

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment.

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Intrastriatal infusion of the Parkinsonian neurotoxin, MPP(+), induces damage of striatal cell nuclei in Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Protocol for the MPTP mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Resveratrol as a therapeutic agent for neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Resveratrol protects against global cerebral ischemic injury in gerbils

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Cytokines and related receptor-mediated signaling pathways

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Interleukin-1beta modulates proinflammatory cytokine production in human epithelial cells

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

CNS injury: the role of the cytokine IL-1.

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Interleukin-1 and neuronal injury

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Interleukin-1 and inflammatory neurodegeneration

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Interleukin-6, a mental cytokine.

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Current opinions and perspectives on the role of immune system in the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

SOCS: role in inflammation, allergy and homeostasis

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Negative regulation of cytokine signaling and immune responses by SOCS proteins

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Multiple mechanisms that prevent excessive brain inflammation

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Regulation of signal transducer and activator of transcription and suppressor of cytokine-signaling gene expression in the brain of mice with astrocyte-targeted production of interleukin-12 or experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

A family of cytokine-inducible inhibitors of signalling

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

A new protein containing an SH2 domain that inhibits JAK kinases

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Suppressor of cytokine signaling 1 inhibits cytokine induction of CD40 expression in macrophages

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function

1 reference

https://api.crossref.org/works/10.1177%2F1753425913488429

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50910086&oldid=2096853547"